研報掘金丨中信建投:維持魚躍醫療“買入”評級,海外業務有望保持快速增長
中信建投證券研報指出,魚躍醫療(002223.SZ)年報業績符合預期,Q1收入略超預期、利潤符合預期。展望全年,隨着國內消費需求復甦和公司市佔率的持續提升,公司國內業務有望延續穩健增長趨勢;隨着公司持續加快海外渠道佈局和品牌建設,公司海外業務有望保持快速增長。短期來看,公司呼吸治療、血糖管理等核心業務具有較強市場競爭力。中長期來看,隨着民衆健康意識的提升,公司新產品的持續迭代和豐富,公司的國內家用醫療器械平臺型龍頭地位有望保持穩固、全球市場份額有望提升。維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.